comparemela.com

Page 4 - Benjamint Dake News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TCG Crossover Management LLC Grows Stake in Aerovate Therapeutics, Inc (NASDAQ:AVTE)

TCG Crossover Management LLC increased its holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) by 103.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,201,274 shares of the company’s stock after buying an additional 1,120,000 shares during the quarter. Aerovate […]

Aerovate Therapeutics, Inc (NASDAQ:AVTE) Insider Sells $203,276 08 in Stock

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Benjamin T. Dake sold 12,517 shares of the stock in a transaction on Monday, November 27th. The shares were sold at an average price of $16.24, for a total value of $203,276.08. Following the sale, the insider now directly owns 1,291 shares in the company, valued […]

Benjamin T Dake Sells 9,382 Shares of Aerovate Therapeutics, Inc (NASDAQ:AVTE) Stock

Benjamin T Dake Sells 9,382 Shares of Aerovate Therapeutics, Inc (NASDAQ:AVTE) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Aerovate Therapeutics, Inc (NASDAQ:AVTE) Insider Sells $142,324 94 in Stock

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Benjamin T. Dake sold 9,382 shares of the firm’s stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $15.17, for a total value of $142,324.94. Following the transaction, the insider now owns 1,291 shares in the company, valued […]

Aerovate Therapeutics, Inc Expected to Earn Q3 2023 Earnings of ($0 65) Per Share (NASDAQ:AVTE)

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) – Stock analysts at Wedbush dropped their Q3 2023 earnings per share (EPS) estimates for shares of Aerovate Therapeutics in a research report issued to clients and investors on Tuesday, August 15th. Wedbush analyst A. Argyrides now expects that the company will post earnings of ($0.65) per share […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.